Impact of SLCO1B1 (OATP1B1) and ABCG2 (BCRP) genetic polymorphisms and inhibition on LDL-C lowering and myopathy of statins.
Xenobiotica. 2011 Aug;41(8):639-51. doi: 10.3109/00498254.2011.562566. Epub 2011 Mar 22.
Xenobiotica. 2011.
PMID: 21425956
Review.